Evaluation of NT PRO BNP Guided Therapy on Hospitalization Rate and Mortality in Patients With Chronic HF NYHA II-IY

NCT00469001 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2010-09-14

No results posted yet for this study

Summary

To use continuous measurement of NT Pro BNP level as guide in therapy patients with CHF.

Conditions

Interventions

PROCEDURE

Treatment according NT Pro BNP level

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Principal Investigators

  • Michael Shochat, MD, PhD · Hillel Yaffe Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2010-01-31
Completion
2010-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00469001 on ClinicalTrials.gov